The Genetics of Neurodevelopment in Congenital Heart Disease

Area of Science:

• Genetics
• Pediatrics
• Neurodevelopmental Science

Background:

• Congenital heart disease (CHD) is the most common birth anomaly, affecting nearly 1% of infants.
• Neurodevelopmental delay is a frequent complication in individuals with CHD, influenced by cardiac physiology, genetics, and environmental factors.
• Genetic factors play a crucial role, particularly in individuals with both CHD and extracardiac anomalies or neurodevelopmental delay.

Purpose of the Study:

• To investigate the role of genetic factors in neurodevelopmental outcomes among individuals with congenital heart disease.
• To identify specific genetic variants and mechanisms contributing to neurodevelopmental delay in CHD.
• To highlight the potential of advanced genetic technologies for improving early intervention strategies.

Main Methods:

• Review of existing literature on genetic contributions to neurodevelopmental delay in CHD.
• Analysis of data from studies utilizing genome-sequencing technologies.
• Examination of specific genetic causes, including large deletions/duplications (e.g., 22q11 deletion syndrome) and single-gene mutations (e.g., CHD7).

Main Results:

• Damaging genetic variants are significantly enriched in individuals with CHD accompanied by extracardiac anomalies or neurodevelopmental delay.
• Genetic factors influence development beyond cardiac tissues, impacting neurodevelopmental outcomes.
• Specific genes (e.g., CHD7) and chromosomal abnormalities (e.g., 22q11 deletion syndrome) are implicated.

Conclusions:

• Genetic factors are critical determinants of neurodevelopmental outcomes in congenital heart disease.
• Genome-sequencing technologies are essential for identifying relevant genetic variants.
• Understanding these genetic links can facilitate timely and targeted learning support interventions for children with CHD.